Literature DB >> 6224219

(Dichloromethylene)diphosphonate-induced impairment of T-lymphocyte function.

G Milhaud, M L Labat, Y Moricard.   

Abstract

The daily subcutaneous administration of (dichloromethylene)diphosphonate (clodronate) to 3-day-old normal inbred Wistar-Furth rats for 30 days produces osteopetrotic bone lesions resembling those of the osteopetrotic mutants. Furthermore, tooth eruption is prevented, growth slows down, and signs of runt disease appear. The weight of the thymus is decreased, and T cells from the thymus and spleen respond weakly to mitogens. These thymic disorders associated with defective bone resorption are very similar to those previously reported in the osteopetrotic mutant op rat and support the hypothesis of a link between the thymus and normal bone modeling and remodeling.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224219      PMCID: PMC384060          DOI: 10.1073/pnas.80.14.4469

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Skeletal changes in murine runt disease.

Authors:  D J Simmons; R L Simmons
Journal:  Am J Anat       Date:  1967-07

2.  Treatment of myositis ossificans progressiva with a diphosphonate.

Authors:  R G Russell; R Smith; M C Bishop; D A Price
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

3.  Inhibition by diphosphonates of bone resorption in mice and comparison with grey-lethal osteopetrosis.

Authors:  J J Reynolds; H Murphy; R C Mühlbauer; D B Morgan; H Fleisch
Journal:  Calcif Tissue Res       Date:  1973

4.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

5.  The influence of two diphosphonates on calcium metabolism in the rat.

Authors:  A B Gasser; D B Morgan; H A Fleisch; L J Richelle
Journal:  Clin Sci       Date:  1972-07       Impact factor: 6.124

6.  [Osteopetrosis with rachitism. Apropos of a case with anatomopathological studies].

Authors:  J Paupe; C Nézeloff; B Denan; J Vialatte
Journal:  Ann Pediatr (Paris)       Date:  1967-10-02

7.  The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates.

Authors:  M D Francis
Journal:  Calcif Tissue Res       Date:  1969

8.  A new method for determining micro quantities of calcium in biological materials.

Authors:  B C Sarkar; U P Chauhan
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

9.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

10.  Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors:  H Fleisch; R G Russell; M D Francis
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more
  7 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 2.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate.

Authors:  A Barbier; J C Breliére; B Remandet; R Roncucci
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

Review 4.  Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.

Authors:  Matthew R Allen
Journal:  Cells Tissues Organs       Date:  2008-08-13       Impact factor: 2.481

5.  Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse.

Authors:  M Horowitz; A Vignery; R K Gershon; R Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment.

Authors:  S Okada; Z Q Wang; A E Grigoriadis; E F Wagner; T von Rüden
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

7.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.